Escalation of drug use in early-onset cannabis users vs Co-twin controls
Identifieur interne : 004F82 ( PascalFrancis/Checkpoint ); précédent : 004F81; suivant : 004F83Escalation of drug use in early-onset cannabis users vs Co-twin controls
Auteurs : Michael T. Lynskey [Australie, France] ; Andrew C. Heath [France] ; Kathleen K. Bucholz [France] ; Wendy S. Slutske [États-Unis] ; Pamela A. F. Madden [France] ; Elliot C. Nelson [France] ; Dixie J. Statham [Australie] ; Nicholas G. Martin [Australie]Source :
- JAMA, the journal of the American Medical Association [ 0098-7484 ] ; 2003.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Toxicomanie, Homme.
English descriptors
- KwdEn :
Abstract
Context Previous studies have reported that early initiation of cannabis (marijuana) use is a significant risk factor for other drug use and drug-related problems. Objective To examine whether the association between early cannabis use and subsequent progression to use of other drugs and drug abuse/dependence persists after controlling for genetic and shared environmental influences. Design Cross-sectional survey conducted in 1996-2000 among an Australian national volunteer sample of 311 young adult (median age, 30 years) monozygotic and dizygotic same-sex twin pairs discordant for early cannabis use (before age 17 years). Main Outcome Measures Self-reported subsequent nonmedical use of prescription sedatives, hallucinogens, cocaine/other stimulants, and opioids; abuse or dependence on these drugs (including cannabis abuse/dependence); and alcohol dependence. Results Individuals who used cannabis by age 17 years had odds of other drug use, alcohol dependence, and drug abuse/dependence that were 2.1 to 5.2 times higher than those of their co-twin, who did not use cannabis before age 17 years. Controlling for known risk factors (early-onset alcohol or tobacco use, parental conflict/ separation, childhood sexual abuse, conduct disorder, major depression, and social anxiety) had only negligible effects on these results. These associations did not differ significantly between monozygotic and dizygotic twins. Conclusions Associations between early cannabis use and later drug use and abuse/ dependence cannot solely be explained by common predisposing genetic or shared environmental factors. The association may arise from the effects of the peer and social context within which cannabis is used and obtained. In particular, early access to and use of cannabis may reduce perceived barriers against the use of other illegal drugs and provide access to these drugs.
Affiliations:
- Australie, France, États-Unis
- Missouri (État)
- Saint-Louis (Missouri)
- Université Washington de Saint-Louis, École de médecine (Université Washington de Saint-Louis)
Links toward previous steps (curation, corpus...)
Links to Exploration step
Pascal:03-0110802Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Escalation of drug use in early-onset cannabis users vs Co-twin controls</title><author><name sortKey="Lynskey, Michael T" sort="Lynskey, Michael T" uniqKey="Lynskey M" first="Michael T." last="Lynskey">Michael T. Lynskey</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Queensland Institute of Medical Research</s1><s2>Brisbane, Queensland</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Queensland Institute of Medical Research</wicri:noRegion></affiliation><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Missouri Alcoholism Research Center and Department of Psychiatry, Washington University School of Medicine</s1><s2>St Louis</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>St Louis</wicri:noRegion><wicri:noRegion>Washington University School of Medicine</wicri:noRegion><placeName><settlement type="city">Saint-Louis (Missouri)</settlement><region type="state">Missouri (État)</region></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName><orgName type="institution">Université Washington de Saint-Louis</orgName></affiliation></author><author><name sortKey="Heath, Andrew C" sort="Heath, Andrew C" uniqKey="Heath A" first="Andrew C." last="Heath">Andrew C. Heath</name><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Missouri Alcoholism Research Center and Department of Psychiatry, Washington University School of Medicine</s1><s2>St Louis</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>St Louis</wicri:noRegion><wicri:noRegion>Washington University School of Medicine</wicri:noRegion><placeName><settlement type="city">Saint-Louis (Missouri)</settlement><region type="state">Missouri (État)</region></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName><orgName type="institution">Université Washington de Saint-Louis</orgName></affiliation></author><author><name sortKey="Bucholz, Kathleen K" sort="Bucholz, Kathleen K" uniqKey="Bucholz K" first="Kathleen K." last="Bucholz">Kathleen K. Bucholz</name><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Missouri Alcoholism Research Center and Department of Psychiatry, Washington University School of Medicine</s1><s2>St Louis</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>St Louis</wicri:noRegion><wicri:noRegion>Washington University School of Medicine</wicri:noRegion><placeName><settlement type="city">Saint-Louis (Missouri)</settlement><region type="state">Missouri (État)</region></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName><orgName type="institution">Université Washington de Saint-Louis</orgName></affiliation></author><author><name sortKey="Slutske, Wendy S" sort="Slutske, Wendy S" uniqKey="Slutske W" first="Wendy S." last="Slutske">Wendy S. Slutske</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Missouri Alcoholism Research Center and Department of Psychology, University of Missouri</s1><s2>Columbia</s2><s3>USA</s3><sZ>4 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Columbia</wicri:noRegion></affiliation></author><author><name sortKey="Madden, Pamela A F" sort="Madden, Pamela A F" uniqKey="Madden P" first="Pamela A. F." last="Madden">Pamela A. F. Madden</name><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Missouri Alcoholism Research Center and Department of Psychiatry, Washington University School of Medicine</s1><s2>St Louis</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>St Louis</wicri:noRegion><wicri:noRegion>Washington University School of Medicine</wicri:noRegion><placeName><settlement type="city">Saint-Louis (Missouri)</settlement><region type="state">Missouri (État)</region></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName><orgName type="institution">Université Washington de Saint-Louis</orgName></affiliation></author><author><name sortKey="Nelson, Elliot C" sort="Nelson, Elliot C" uniqKey="Nelson E" first="Elliot C." last="Nelson">Elliot C. Nelson</name><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Missouri Alcoholism Research Center and Department of Psychiatry, Washington University School of Medicine</s1><s2>St Louis</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>St Louis</wicri:noRegion><wicri:noRegion>Washington University School of Medicine</wicri:noRegion><placeName><settlement type="city">Saint-Louis (Missouri)</settlement><region type="state">Missouri (État)</region></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName><orgName type="institution">Université Washington de Saint-Louis</orgName></affiliation></author><author><name sortKey="Statham, Dixie J" sort="Statham, Dixie J" uniqKey="Statham D" first="Dixie J." last="Statham">Dixie J. Statham</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Queensland Institute of Medical Research</s1><s2>Brisbane, Queensland</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Queensland Institute of Medical Research</wicri:noRegion></affiliation></author><author><name sortKey="Martin, Nicholas G" sort="Martin, Nicholas G" uniqKey="Martin N" first="Nicholas G." last="Martin">Nicholas G. Martin</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Queensland Institute of Medical Research</s1><s2>Brisbane, Queensland</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Queensland Institute of Medical Research</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">03-0110802</idno><date when="2003">2003</date><idno type="stanalyst">PASCAL 03-0110802 INIST</idno><idno type="RBID">Pascal:03-0110802</idno><idno type="wicri:Area/PascalFrancis/Corpus">005445</idno><idno type="wicri:Area/PascalFrancis/Curation">000C81</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">004F82</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">004F82</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Escalation of drug use in early-onset cannabis users vs Co-twin controls</title><author><name sortKey="Lynskey, Michael T" sort="Lynskey, Michael T" uniqKey="Lynskey M" first="Michael T." last="Lynskey">Michael T. Lynskey</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Queensland Institute of Medical Research</s1><s2>Brisbane, Queensland</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Queensland Institute of Medical Research</wicri:noRegion></affiliation><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Missouri Alcoholism Research Center and Department of Psychiatry, Washington University School of Medicine</s1><s2>St Louis</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>St Louis</wicri:noRegion><wicri:noRegion>Washington University School of Medicine</wicri:noRegion><placeName><settlement type="city">Saint-Louis (Missouri)</settlement><region type="state">Missouri (État)</region></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName><orgName type="institution">Université Washington de Saint-Louis</orgName></affiliation></author><author><name sortKey="Heath, Andrew C" sort="Heath, Andrew C" uniqKey="Heath A" first="Andrew C." last="Heath">Andrew C. Heath</name><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Missouri Alcoholism Research Center and Department of Psychiatry, Washington University School of Medicine</s1><s2>St Louis</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>St Louis</wicri:noRegion><wicri:noRegion>Washington University School of Medicine</wicri:noRegion><placeName><settlement type="city">Saint-Louis (Missouri)</settlement><region type="state">Missouri (État)</region></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName><orgName type="institution">Université Washington de Saint-Louis</orgName></affiliation></author><author><name sortKey="Bucholz, Kathleen K" sort="Bucholz, Kathleen K" uniqKey="Bucholz K" first="Kathleen K." last="Bucholz">Kathleen K. Bucholz</name><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Missouri Alcoholism Research Center and Department of Psychiatry, Washington University School of Medicine</s1><s2>St Louis</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>St Louis</wicri:noRegion><wicri:noRegion>Washington University School of Medicine</wicri:noRegion><placeName><settlement type="city">Saint-Louis (Missouri)</settlement><region type="state">Missouri (État)</region></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName><orgName type="institution">Université Washington de Saint-Louis</orgName></affiliation></author><author><name sortKey="Slutske, Wendy S" sort="Slutske, Wendy S" uniqKey="Slutske W" first="Wendy S." last="Slutske">Wendy S. Slutske</name><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Missouri Alcoholism Research Center and Department of Psychology, University of Missouri</s1><s2>Columbia</s2><s3>USA</s3><sZ>4 aut.</sZ></inist:fA14><country>États-Unis</country><wicri:noRegion>Columbia</wicri:noRegion></affiliation></author><author><name sortKey="Madden, Pamela A F" sort="Madden, Pamela A F" uniqKey="Madden P" first="Pamela A. F." last="Madden">Pamela A. F. Madden</name><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Missouri Alcoholism Research Center and Department of Psychiatry, Washington University School of Medicine</s1><s2>St Louis</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>St Louis</wicri:noRegion><wicri:noRegion>Washington University School of Medicine</wicri:noRegion><placeName><settlement type="city">Saint-Louis (Missouri)</settlement><region type="state">Missouri (État)</region></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName><orgName type="institution">Université Washington de Saint-Louis</orgName></affiliation></author><author><name sortKey="Nelson, Elliot C" sort="Nelson, Elliot C" uniqKey="Nelson E" first="Elliot C." last="Nelson">Elliot C. Nelson</name><affiliation wicri:level="4"><inist:fA14 i1="02"><s1>Missouri Alcoholism Research Center and Department of Psychiatry, Washington University School of Medicine</s1><s2>St Louis</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><wicri:noRegion>St Louis</wicri:noRegion><wicri:noRegion>Washington University School of Medicine</wicri:noRegion><placeName><settlement type="city">Saint-Louis (Missouri)</settlement><region type="state">Missouri (État)</region></placeName><orgName type="university">École de médecine (Université Washington de Saint-Louis)</orgName><orgName type="institution">Université Washington de Saint-Louis</orgName></affiliation></author><author><name sortKey="Statham, Dixie J" sort="Statham, Dixie J" uniqKey="Statham D" first="Dixie J." last="Statham">Dixie J. Statham</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Queensland Institute of Medical Research</s1><s2>Brisbane, Queensland</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Queensland Institute of Medical Research</wicri:noRegion></affiliation></author><author><name sortKey="Martin, Nicholas G" sort="Martin, Nicholas G" uniqKey="Martin N" first="Nicholas G." last="Martin">Nicholas G. Martin</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Queensland Institute of Medical Research</s1><s2>Brisbane, Queensland</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></inist:fA14><country>Australie</country><wicri:noRegion>Queensland Institute of Medical Research</wicri:noRegion></affiliation></author></analytic><series><title level="j" type="main">JAMA, the journal of the American Medical Association</title><title level="j" type="abbreviated">JAMA j. Am. Med. Assoc.</title><idno type="ISSN">0098-7484</idno><imprint><date when="2003">2003</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">JAMA, the journal of the American Medical Association</title><title level="j" type="abbreviated">JAMA j. Am. Med. Assoc.</title><idno type="ISSN">0098-7484</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cannabis</term><term>Drug addiction</term><term>Early</term><term>Epidemiology</term><term>Human</term><term>Illicit drug</term><term>Risk factor</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Cannabis</term><term>Drogue illicite</term><term>Toxicomanie</term><term>Facteur risque</term><term>Homme</term><term>Précoce</term><term>Epidémiologie</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Toxicomanie</term><term>Homme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Context Previous studies have reported that early initiation of cannabis (marijuana) use is a significant risk factor for other drug use and drug-related problems. Objective To examine whether the association between early cannabis use and subsequent progression to use of other drugs and drug abuse/dependence persists after controlling for genetic and shared environmental influences. Design Cross-sectional survey conducted in 1996-2000 among an Australian national volunteer sample of 311 young adult (median age, 30 years) monozygotic and dizygotic same-sex twin pairs discordant for early cannabis use (before age 17 years). Main Outcome Measures Self-reported subsequent nonmedical use of prescription sedatives, hallucinogens, cocaine/other stimulants, and opioids; abuse or dependence on these drugs (including cannabis abuse/dependence); and alcohol dependence. Results Individuals who used cannabis by age 17 years had odds of other drug use, alcohol dependence, and drug abuse/dependence that were 2.1 to 5.2 times higher than those of their co-twin, who did not use cannabis before age 17 years. Controlling for known risk factors (early-onset alcohol or tobacco use, parental conflict/ separation, childhood sexual abuse, conduct disorder, major depression, and social anxiety) had only negligible effects on these results. These associations did not differ significantly between monozygotic and dizygotic twins. Conclusions Associations between early cannabis use and later drug use and abuse/ dependence cannot solely be explained by common predisposing genetic or shared environmental factors. The association may arise from the effects of the peer and social context within which cannabis is used and obtained. In particular, early access to and use of cannabis may reduce perceived barriers against the use of other illegal drugs and provide access to these drugs.</div></front></TEI><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0098-7484</s0></fA01><fA03 i2="1"><s0>JAMA j. Am. Med. Assoc.</s0></fA03><fA05><s2>289</s2></fA05><fA06><s2>4</s2></fA06><fA08 i1="01" i2="1" l="ENG"><s1>Escalation of drug use in early-onset cannabis users vs Co-twin controls</s1></fA08><fA11 i1="01" i2="1"><s1>LYNSKEY (Michael T.)</s1></fA11><fA11 i1="02" i2="1"><s1>HEATH (Andrew C.)</s1></fA11><fA11 i1="03" i2="1"><s1>BUCHOLZ (Kathleen K.)</s1></fA11><fA11 i1="04" i2="1"><s1>SLUTSKE (Wendy S.)</s1></fA11><fA11 i1="05" i2="1"><s1>MADDEN (Pamela A. F.)</s1></fA11><fA11 i1="06" i2="1"><s1>NELSON (Elliot C.)</s1></fA11><fA11 i1="07" i2="1"><s1>STATHAM (Dixie J.)</s1></fA11><fA11 i1="08" i2="1"><s1>MARTIN (Nicholas G.)</s1></fA11><fA14 i1="01"><s1>Queensland Institute of Medical Research</s1><s2>Brisbane, Queensland</s2><s3>AUS</s3><sZ>1 aut.</sZ><sZ>7 aut.</sZ><sZ>8 aut.</sZ></fA14><fA14 i1="02"><s1>Missouri Alcoholism Research Center and Department of Psychiatry, Washington University School of Medicine</s1><s2>St Louis</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></fA14><fA14 i1="03"><s1>Missouri Alcoholism Research Center and Department of Psychology, University of Missouri</s1><s2>Columbia</s2><s3>USA</s3><sZ>4 aut.</sZ></fA14><fA20><s1>427-433</s1></fA20><fA21><s1>2003</s1></fA21><fA23 i1="01"><s0>ENG</s0></fA23><fA43 i1="01"><s1>INIST</s1><s2>5051</s2><s5>354000103743700010</s5></fA43><fA44><s0>0000</s0><s1>© 2003 INIST-CNRS. All rights reserved.</s1></fA44><fA45><s0>42 ref.</s0></fA45><fA47 i1="01" i2="1"><s0>03-0110802</s0></fA47><fA60><s1>P</s1></fA60><fA61><s0>A</s0></fA61><fA64 i1="01" i2="1"><s0>JAMA, the journal of the American Medical Association</s0></fA64><fA66 i1="01"><s0>USA</s0></fA66><fC01 i1="01" l="ENG"><s0>Context Previous studies have reported that early initiation of cannabis (marijuana) use is a significant risk factor for other drug use and drug-related problems. Objective To examine whether the association between early cannabis use and subsequent progression to use of other drugs and drug abuse/dependence persists after controlling for genetic and shared environmental influences. Design Cross-sectional survey conducted in 1996-2000 among an Australian national volunteer sample of 311 young adult (median age, 30 years) monozygotic and dizygotic same-sex twin pairs discordant for early cannabis use (before age 17 years). Main Outcome Measures Self-reported subsequent nonmedical use of prescription sedatives, hallucinogens, cocaine/other stimulants, and opioids; abuse or dependence on these drugs (including cannabis abuse/dependence); and alcohol dependence. Results Individuals who used cannabis by age 17 years had odds of other drug use, alcohol dependence, and drug abuse/dependence that were 2.1 to 5.2 times higher than those of their co-twin, who did not use cannabis before age 17 years. Controlling for known risk factors (early-onset alcohol or tobacco use, parental conflict/ separation, childhood sexual abuse, conduct disorder, major depression, and social anxiety) had only negligible effects on these results. These associations did not differ significantly between monozygotic and dizygotic twins. Conclusions Associations between early cannabis use and later drug use and abuse/ dependence cannot solely be explained by common predisposing genetic or shared environmental factors. The association may arise from the effects of the peer and social context within which cannabis is used and obtained. In particular, early access to and use of cannabis may reduce perceived barriers against the use of other illegal drugs and provide access to these drugs.</s0></fC01><fC02 i1="01" i2="X"><s0>002B03D</s0></fC02><fC03 i1="01" i2="X" l="FRE"><s0>Cannabis</s0><s2>NS</s2><s5>01</s5></fC03><fC03 i1="01" i2="X" l="ENG"><s0>Cannabis</s0><s2>NS</s2><s5>01</s5></fC03><fC03 i1="01" i2="X" l="SPA"><s0>Cannabis</s0><s2>NS</s2><s5>01</s5></fC03><fC03 i1="02" i2="X" l="FRE"><s0>Drogue illicite</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="ENG"><s0>Illicit drug</s0><s5>02</s5></fC03><fC03 i1="02" i2="X" l="SPA"><s0>Droga ilícita</s0><s5>02</s5></fC03><fC03 i1="03" i2="X" l="FRE"><s0>Toxicomanie</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="ENG"><s0>Drug addiction</s0><s5>03</s5></fC03><fC03 i1="03" i2="X" l="SPA"><s0>Toxicomanía</s0><s5>03</s5></fC03><fC03 i1="04" i2="X" l="FRE"><s0>Facteur risque</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="ENG"><s0>Risk factor</s0><s5>04</s5></fC03><fC03 i1="04" i2="X" l="SPA"><s0>Factor riesgo</s0><s5>04</s5></fC03><fC03 i1="05" i2="X" l="FRE"><s0>Homme</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="ENG"><s0>Human</s0><s5>05</s5></fC03><fC03 i1="05" i2="X" l="SPA"><s0>Hombre</s0><s5>05</s5></fC03><fC03 i1="06" i2="X" l="FRE"><s0>Précoce</s0><s5>06</s5></fC03><fC03 i1="06" i2="X" l="ENG"><s0>Early</s0><s5>06</s5></fC03><fC03 i1="06" i2="X" l="SPA"><s0>Precoz</s0><s5>06</s5></fC03><fC03 i1="07" i2="X" l="FRE"><s0>Epidémiologie</s0><s5>07</s5></fC03><fC03 i1="07" i2="X" l="ENG"><s0>Epidemiology</s0><s5>07</s5></fC03><fC03 i1="07" i2="X" l="SPA"><s0>Epidemiología</s0><s5>07</s5></fC03><fC07 i1="01" i2="X" l="FRE"><s0>Cannabidaceae</s0><s2>NS</s2></fC07><fC07 i1="01" i2="X" l="ENG"><s0>Cannabidaceae</s0><s2>NS</s2></fC07><fC07 i1="01" i2="X" l="SPA"><s0>Cannabidaceae</s0><s2>NS</s2></fC07><fC07 i1="02" i2="X" l="FRE"><s0>Dicotyledones</s0><s2>NS</s2></fC07><fC07 i1="02" i2="X" l="ENG"><s0>Dicotyledones</s0><s2>NS</s2></fC07><fC07 i1="02" i2="X" l="SPA"><s0>Dicotyledones</s0><s2>NS</s2></fC07><fC07 i1="03" i2="X" l="FRE"><s0>Angiospermae</s0><s2>NS</s2></fC07><fC07 i1="03" i2="X" l="ENG"><s0>Angiospermae</s0><s2>NS</s2></fC07><fC07 i1="03" i2="X" l="SPA"><s0>Angiospermae</s0><s2>NS</s2></fC07><fC07 i1="04" i2="X" l="FRE"><s0>Spermatophyta</s0><s2>NS</s2></fC07><fC07 i1="04" i2="X" l="ENG"><s0>Spermatophyta</s0><s2>NS</s2></fC07><fC07 i1="04" i2="X" l="SPA"><s0>Spermatophyta</s0><s2>NS</s2></fC07><fC07 i1="05" i2="X" l="FRE"><s0>Santé publique</s0><s5>37</s5></fC07><fC07 i1="05" i2="X" l="ENG"><s0>Public health</s0><s5>37</s5></fC07><fC07 i1="05" i2="X" l="SPA"><s0>Salud pública</s0><s5>37</s5></fC07><fN21><s1>062</s1></fN21><fN82><s1>PSI</s1></fN82></pA></standard></inist><affiliations><list><country><li>Australie</li><li>France</li><li>États-Unis</li></country><region><li>Missouri (État)</li></region><settlement><li>Saint-Louis (Missouri)</li></settlement><orgName><li>Université Washington de Saint-Louis</li><li>École de médecine (Université Washington de Saint-Louis)</li></orgName></list><tree><country name="Australie"><noRegion><name sortKey="Lynskey, Michael T" sort="Lynskey, Michael T" uniqKey="Lynskey M" first="Michael T." last="Lynskey">Michael T. Lynskey</name></noRegion><name sortKey="Martin, Nicholas G" sort="Martin, Nicholas G" uniqKey="Martin N" first="Nicholas G." last="Martin">Nicholas G. Martin</name><name sortKey="Statham, Dixie J" sort="Statham, Dixie J" uniqKey="Statham D" first="Dixie J." last="Statham">Dixie J. Statham</name></country><country name="France"><region name="Missouri (État)"><name sortKey="Lynskey, Michael T" sort="Lynskey, Michael T" uniqKey="Lynskey M" first="Michael T." last="Lynskey">Michael T. Lynskey</name></region><name sortKey="Bucholz, Kathleen K" sort="Bucholz, Kathleen K" uniqKey="Bucholz K" first="Kathleen K." last="Bucholz">Kathleen K. Bucholz</name><name sortKey="Heath, Andrew C" sort="Heath, Andrew C" uniqKey="Heath A" first="Andrew C." last="Heath">Andrew C. Heath</name><name sortKey="Madden, Pamela A F" sort="Madden, Pamela A F" uniqKey="Madden P" first="Pamela A. F." last="Madden">Pamela A. F. Madden</name><name sortKey="Nelson, Elliot C" sort="Nelson, Elliot C" uniqKey="Nelson E" first="Elliot C." last="Nelson">Elliot C. Nelson</name></country><country name="États-Unis"><noRegion><name sortKey="Slutske, Wendy S" sort="Slutske, Wendy S" uniqKey="Slutske W" first="Wendy S." last="Slutske">Wendy S. Slutske</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004F82 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 004F82 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PascalFrancis
|étape= Checkpoint
|type= RBID
|clé= Pascal:03-0110802
|texte= Escalation of drug use in early-onset cannabis users vs Co-twin controls
}}
| This area was generated with Dilib version V0.6.33. |  |